Streetbeat News

Price Targets

ADBE

Adobe, Inc (NASDAQ:ABDE) is set to release its Q2 financial results, with analysts expecting EPS of $3.79 on revenues of $4.43 billion. JPMorgan analyst Sterling Auty maintained a Neutral rating on Adobe and raised the price target from $380 to $450. Three other analysts have also increased their price targets to between $470 and $530.

Portfolio Pulse from Melanie Schaffer

June 15, 2023 | 7:16 pm

GOOG

MSFT

Microsoft's strategic partnership with OpenAI and investments in artificial intelligence have fueled its stock growth, reaching an all-time high of $346. Analysts from Mizuho and J.P. Morgan raised Microsoft's one-year price target, and CEO Satya Nadella aims for real competition with Google in the AI-powered search engine market.

Portfolio Pulse from Natan Ponieman

June 15, 2023 | 7:01 pm

MSFT

In the last 3 months, 49 analysts have offered 12-month price targets for Microsoft, with an average price target of $339.82, a high of $420.00, and a low of $290.00. The average price target has increased by 9.06% over the past month.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 7:00 pm

ACN

Accenture's stock is trading higher following an upgrade from Piper Sandler, which changed its rating from Underweight to Neutral and increased its price target from $250 to $316.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 6:44 pm

PYPL

PayPal Holdings shares are trading higher after BTIG initiated coverage on the stock with a Buy rating and an $85 price target.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 6:38 pm

OPRA

Opera shares are trading higher after Lake Street maintained a Buy rating on the stock and raised its price target from $14 to $22.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 6:37 pm

DRI

KeyBanc Capital Markets analyst Eric Gonzalez reiterated an Overweight rating on Darden Restaurants, Inc. (NYSE:DRI) and raised the price target to $185 from $170. The analyst is bullish on Darden's recent acquisition of Ruth's Hospitality Group, Inc, which is expected to add to EPS in FY24 and FY25.

Portfolio Pulse from Nabaparna Bhattacharya

June 15, 2023 | 6:12 pm

IMGN

MRSN

Guggenheim Partners has initiated coverage on Mersana Therapeutics Inc (NASDAQ:MRSN) with a Buy rating and a price target of $14. The company's main near-term value driver is Upifitamab rilsodotin (UpRi), which shows potential in ovarian cancer. Investor sentiment on MRSN's stock improved following positive disclosures from peer company Immunogen Inc (NASDAQ: IMGN).

Portfolio Pulse from Vandana Singh

June 15, 2023 | 6:12 pm

HUM

Over the past 3 months, 10 analysts have published their opinion on Humana (NYSE:HUM) stock, with 9 being somewhat bullish and 1 indifferent. The average 12-month price target for Humana is $611.0, with a high of $637.00 and a low of $576.00, increasing by 0.96% from the previous average of $605.20.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 6:02 pm

DPZ

Domino's Pizza (DPZ) stock is rising after Stifel upgraded its rating from Hold to Buy and raised its price target from $320 to $350 per share. The upgrade is based on Domino's plans to enhance its ordering app and loyalty program, lower commodity costs, and growth opportunities in the customer carry-out channel.

Portfolio Pulse from Erica Kollmann

June 15, 2023 | 5:38 pm